To Tell the Truth, the Whole Truth, May Do Patients Harm: The Problem of the Nocebo Effect for Informed Consent

被引:197
作者
Wells, Rebecca Erwin [1 ,2 ]
Kaptchuk, Ted J. [3 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, John R Graham Med Ctr, Boston, MA 02130 USA
[2] Harvard Univ, Sch Med, Faulkner Hosp, Boston, MA 02130 USA
[3] Harvard Univ, Sch Med, Beth Israel Deaoness Med Ctr, Boston, MA 02130 USA
基金
美国国家卫生研究院;
关键词
decision making; informed consent; professional ethics; professional-patient relationship; PLACEBO GROUPS; HEALTH; MECHANISMS; MORBIDITY; AUTONOMY; THERAPY; EVENTS; TRIALS; WORDS; RISK;
D O I
10.1080/15265161.2011.652798
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
The principle of informed consent obligates physicians to explain possible side effects when prescribing medications. This disclosure may itself induce adverse effects through expectancy mechanisms known as nocebo effects, contradicting the principle of nonmaleficence. Rigorous research suggests that providing patients with a detailed enumeration of every possible adverse event-especially subjective self-appraised symptoms-can actually increase side effects. Describing one version of what might happen (clinical "facts") may actually create outcomes that are different from what would have happened without this information (another version of "facts"). This essay argues that the perceived tension between balancing informed consent with nonmaleficence might be resolved by recognizing that adverse effects have no clear black or white "truth." This essay suggests a pragmatic approach for providers to minimize nocebo responses while still maintaining patient autonomy through "contextualized informed consent," which takes into account possible side effects, the patient being treated, and the particular diagnosis involved.
引用
收藏
页码:22 / 29
页数:8
相关论文
共 48 条
[1]  
Ainslie G., 2001, BREAKDOWN WILL
[2]   A systematic review of adverse events in placebo groups of anti-migraine clinical trials [J].
Amanzio, Martina ;
Corazzini, Luca Latini ;
Vase, Lene ;
Benedetti, Fabrizio .
PAIN, 2009, 146 (03) :261-269
[3]  
Barilan YM, 2010, MED HEALTH CARE PHIL, V13, P89, DOI 10.1007/s11019-009-9200-4
[4]   Nonspecific medication side effects and the nocebo phenomenon [J].
Barsky, AJ ;
Saintfort, R ;
Rogers, MP ;
Borus, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (05) :622-627
[5]   Functional somatic syndromes [J].
Barsky, AJ ;
Borus, JF .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (11) :910-921
[6]   When words are painful: Unraveling the mechanisms of the nocebo effect [J].
Benedetti, F. ;
Lanotte, M. ;
Lopiano, L. ;
Colloca, L. .
NEUROSCIENCE, 2007, 147 (02) :260-271
[7]   POTENTIATION OF PLACEBO ANALGESIA BY PROGLUMIDE [J].
BENEDETTI, F ;
AMANZIO, M ;
MAGGI, G .
LANCET, 1995, 346 (8984) :1231-1231
[8]   The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect [J].
Benedetti, Fabrizio ;
Amanzio, Martina ;
Vighetti, Sergio ;
Asteggiano, Giovanni .
JOURNAL OF NEUROSCIENCE, 2006, 26 (46) :12014-12022
[9]   Drug intolerance due to nonspecific adverse effects related to psychiatric morbidity in hypertensive patients [J].
Davies, SJC ;
Jackson, PR ;
Ramsay, LE ;
Ghahramani, P .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :592-600
[10]   Placebo and Nocebo Effects in Randomized Double-Blind Clinical Trials of Agents for the Therapy for Fatigue in Patients With Advanced Cancer [J].
de la Cruz, Maxine ;
Hui, David ;
Parsons, Henrique A. ;
Bruera, Eduardo .
CANCER, 2010, 116 (03) :766-774